A new trading day began on Monday, with Viking Therapeutics Inc (NASDAQ: VKTX) stock price up 2.73% from the previous day of trading, before settling in for the closing price of $61.63. VKTX’s price has ranged from $8.28 to $99.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -8.42%. With a float of $103.66 million, this company’s outstanding shares have now reached $110.80 million.
The firm has a total of 27 workers. Let’s measure their productivity.
Viking Therapeutics Inc (VKTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 6.44%, while institutional ownership is 73.93%. The most recent insider transaction that took place on Sep 20 ’24, was worth 715,850. In this transaction Director of this company sold 10,300 shares at a rate of $69.50, taking the stock ownership to the 9,500 shares. Before that another transaction happened on Sep 20 ’24, when Company’s President & CEO sold 216,130 for $70.83, making the entire transaction worth $15,308,553. This insider now owns 2,304,927 shares in total.
Viking Therapeutics Inc (VKTX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -8.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to -18.89% drop over the previous five years of trading.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Here are Viking Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 37.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Analysing the last 5-days average volume posted by the [Viking Therapeutics Inc, VKTX], we can find that recorded value of 2.49 million was lower than the volume posted last year of 4.48 million. As of the previous 9 days, the stock’s Stochastic %D was 9.93%. Additionally, its Average True Range was 3.94.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 48.18%, which indicates a significant increase from 44.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.71% in the past 14 days, which was lower than the 84.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $60.00, while its 200-day Moving Average is $54.13. Now, the first resistance to watch is $64.77. This is followed by the second major resistance level at $66.23. The third major resistance level sits at $67.91. If the price goes on to break the first support level at $61.63, it is likely to go to the next support level at $59.95. Should the price break the second support level, the third support level stands at $58.49.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
With a market capitalization of 7.01 billion, the company has a total of 110,268K Shares Outstanding. Currently, annual sales are 0 K while annual income is -85,900 K. The company’s previous quarter sales were 0 K while its latest quarter income was -22,250 K.
